[1]
Narwade, S.D. and Barve, R.M. 2020. Assessment of comorbidities in patients with deranged thyroid hormone levels. International Journal of Basic & Clinical Pharmacology. 9, 7 (Jun. 2020), 1044–1049. DOI:https://doi.org/10.18203/2319-2003.ijbcp20202938.